Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Satsuma Pharmaceuticals, Inc. STSA

Full chart Compare
Set alert

Price alert · STSA

All alert types
1.10 0.00 (+0.00%)

At closeJun 7, 2023, 4:00 PM EDT

1.10 Day range 1.10

52-week range unavailable

Financial health

Altman Z-Score

-7.32 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2017: -22.2×FY 2018: -9.1×FY 2019: -4.0×FY 2020: -1.7×FY 2021: -2.6×FY 2022: -0.4×
FY 2017 5y median -2.6× FY 2022
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2017 5y median 0.0× FY 2022
P/B -0.1×
FY 2017: -21.2×FY 2018: -5.5×FY 2019: -2.7×FY 2020: -0.9×FY 2021: 1.3×FY 2022: -0.1×
FY 2017 5y median -0.9× FY 2022
P/FCF -0.6×
FY 2017: -26.3×FY 2018: -9.0×FY 2019: -3.8×FY 2020: -1.7×FY 2021: -2.9×FY 2022: -0.6×
FY 2017 5y median -2.9× FY 2022
EV/EBITDA -0.2×
FY 2017: -22.0×FY 2018: -9.2×FY 2019: -3.5×FY 2020: -1.0×FY 2021: -2.3×FY 2022: -0.2×
FY 2017 5y median -2.3× FY 2022
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2017 5y median 0.0× FY 2022
FCF Yield -180.4%
FY 2017: -3.8%FY 2018: -11.1%FY 2019: -26.2%FY 2020: -59.2%FY 2021: -34.3%FY 2022: -180.4%
FY 2017 5y median -34.3% FY 2022

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022
ROE 32.7%
FY 2017: 95.2%FY 2018: 60.6%FY 2019: 66.3%FY 2020: 52.6%FY 2021: -50.6%FY 2022: 32.7%
FY 2017 5y median 52.6% FY 2022
ROIC -149.1%
FY 2017: -1741.9%FY 2018: -164.9%FY 2019: -24.0%FY 2020: -64.5%FY 2021: -50.0%FY 2022: -149.1%
FY 2017 5y median -64.5% FY 2022
ROA -125.9%
FY 2017: -260.7%FY 2018: -115.1%FY 2019: -22.6%FY 2020: -58.8%FY 2021: -46.7%FY 2022: -125.9%
FY 2017 5y median -58.8% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 FY 2022
Operating Income -38.7%
FY 2017: 0.0%FY 2018: -51.9%FY 2019: -284.3%FY 2020: -67.3%FY 2021: -5.9%FY 2022: -38.7%
FY 2017 FY 2022
EPS (diluted) -22.7%
FY 2017: 0.0%FY 2018: -144.7%FY 2019: -161.3%FY 2020: 43.6%FY 2021: 35.8%FY 2022: -22.7%
FY 2017 FY 2022
Free Cash Flow -15.5%
FY 2017: 0.0%FY 2018: -68.6%FY 2019: -308.9%FY 2020: -57.3%FY 2021: 5.2%FY 2022: -15.5%
FY 2017 FY 2022

Financial Health

Current Ratio 6.8×
FY 2017: 1.1×FY 2018: 2.8×FY 2019: 14.4×FY 2020: 9.2×FY 2021: 11.8×FY 2022: 6.8×
FY 2017 5y median 9.2× FY 2022
Quick Ratio 6.8×
FY 2017: 1.1×FY 2018: 2.8×FY 2019: 14.4×FY 2020: 9.2×FY 2021: 11.8×FY 2022: 6.8×
FY 2017 5y median 9.2× FY 2022
Debt / Equity -0.0×
FY 2017: -0.0×FY 2018: -0.4×FY 2019: -0.1×FY 2020: -0.0×FY 2021: 0.0×FY 2022: -0.0×
FY 2017 5y median -0.0× FY 2022
Net Debt / EBITDA 0.2×
FY 2017: 0.3×FY 2018: 0.0×FY 2019: 0.6×FY 2020: 0.7×FY 2021: 0.3×FY 2022: 0.2×
FY 2017 5y median 0.3× FY 2022
Interest Coverage -5457×
FY 2017: -330×FY 2018: -83.5×FY 2019: -59.9×FY 2020: -138×FY 2021: -314×FY 2022: -5457×
FY 2017 5y median -138× FY 2022

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31